Your session is about to expire
← Back to Search
Other
CHRP-BB for Substance Abuse (CHRP-BB Trial)
N/A
Waitlist Available
Led By Michael Copenhaver, PhD
Research Sponsored by University of Connecticut
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up over a 9-month period
Awards & highlights
CHRP-BB Trial Summary
This trial will test a new approach to preventing HIV among people who inject drugs, which includes a medication (PrEP) and a behavioral program to help people stick to the medication.
Eligible Conditions
- Substance Abuse
- Risky Behaviors
- HIV/AIDS
- Medication Adherence
CHRP-BB Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ over a 9-month period
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~over a 9-month period
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
HIV risk reduction behaviors
PrEP adherence
Secondary outcome measures
IMB measures related to PrEP adherence and HIV risk reduction
CHRP-BB Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: CHRP-BBExperimental Treatment1 Intervention
Patients assigned to the CHRP-BB will receive a weekly HIV risk reduction and PrEP adherence group level intervention led by two facilitators trained and supervised by the PI, a licensed clinical psychologist. It is a substantially shortened version of the comprehensive Holistic Health Recovery Program (HHRP)-based interventions that have been identified as demonstrating evidence of effectiveness in two randomized clinical trials. The CHRP-BB, which includes four 50-minute groups (1 group per week), will contain only content that relates explicitly to drug- or sex-related HIV risk reduction and PrEP adherence. Participants in both conditions will receive routine clinical services (i.e., daily methadone and case management).
Group II: Control ConditionActive Control1 Intervention
The time-and-attention-matched control condition for the proposed research will be a time and contact-matched, non-contaminating support group for individuals in recovery modeled after similar groups offered in the community. There will be no overlap between the content of the comparison intervention and experimental intervention although the basic structure will be the same. Thus, each participant will be asked to attend four 50-minute weekly group sessions led by two trained facilitators. Participants in both conditions will receive routine clinical services (i.e., daily methadone and case management).
Find a Location
Who is running the clinical trial?
University of ConnecticutLead Sponsor
181 Previous Clinical Trials
157,808 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,464 Previous Clinical Trials
2,618,356 Total Patients Enrolled
152 Trials studying Substance Abuse
706,905 Patients Enrolled for Substance Abuse
APT Foundation, Inc.OTHER
5 Previous Clinical Trials
646 Total Patients Enrolled
1 Trials studying Substance Abuse
120 Patients Enrolled for Substance Abuse
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies for volunteers in this medical experiment?
"As per clinicaltrials.gov, this trial is actively recruiting participants since it was initially posted on September 1st 2017 and recently modified on June 7th 2022."
Answered by AI
How many individuals can partake in this investigation at any one time?
"Affirmative. According to clinicaltrials.gov, the recruitment for this research project, which was posted on September 1st 2017 and most recently updated on June 7th 2022, is still ongoing. The study has a capacity of 300 participants across one site."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger